Cardiovascular Devices: Technologies and Global Markets

Cardiovascular Devices: Technologies and Global Markets published by BCC Research in November, 2009. This report consists of 196 pages and the price starts from US $ 4850.

Introduction

Abstract

• Offer a comprehensive view of the cardiovascular devices industry on a worldwide basis
• Provide an overview of the major types of cardiovascular diagnostic equipment, including electrophysiology lab systems, vascular probes, arterial and venous diagnosis, electro anatomical mapping systems, transesophageal atrial pacing, stress-testing equipment, ECG monitors and more
• Forecast the global market for cardiovascular devices, with data for 2008, estimates for 2009, and 5-year compound annual growth rates (CAGRs) through 2014
• Consider regulations in the U.S. and global markets, identifying consumer safety, product introduction and product safety regulatory issues
• Discuss the technological issues, including the latest trends and developments
• Profile the major players within the industry and provide a detailed patent analysis.

SCOPE OF REPORT

The scope of this study encompasses several different specific technology- and procedural-based areas relating directly to cardiovascular devices, focusing primarily on those industry stakeholders providing advanced technological solutions for human conditions but also including a smaller, less-granulated analysis of comparable products offered for diagnostic and screening purposes. We will lightly cover some of the pediatric cardiovascular devices, although, in truth, the pediatric market is differently “shaped” and disparately funded through many nonprofit organizations, making revenues not completely comparable.

BCC analyzed the industry on a worldwide basis, both from a market and product perspective and a technology perspective. Regulations in the U.S. and global markets were also examined to identify consumer safety, product introduction, and product safety regulatory issues for stakeholders and potential stakeholders in this industry. Many companies identify their product lines by making the distinction of whether products have been “FDA-cleared.” We will explain the FDA screening process in order for readers to more fully understand the distinctions made between “FDA-cleared” devices and those developed in other countries that either have not sought or have not received FDA approval.

Considerations have been taken for the changing economy and all statistical reporting and forecasting takes into account current trends and other available data indicating company, product and application stability or instability. Clearly, not every factor can be taken into account, particularly because companies with no indication of financial instability have gone seemingly instantly from near giants in their field to bankruptcy and dissolution. In reality, close scrutiny of financial reporting should reveal many such trends; however, there are increasing indications that either through inefficient or positively deceptive accounting and fiscal reporting or through mismanagement, a remarkably large number of these companies claim to have genuinely been unaware of their pending status change.

Market segment financial numbers are based on real reported revenue and primary investigation, and interviews and conventional statistical estimation and forecasting algorithms and techniques are used to report financial trending.

METHODOLOGY

BCC presents an analysis across the entire cardiovascular device market based on reported revenue dollars and units shipped as reported to the SEC and/or other governmental agencies. We also analyze data gathered from various research sources via the Internet, including large databases such as the United States Patent Office (USPTO) databases of U.S. Patents and Patent Applications, Micropatent' s searchable databases for U.S. and international patents and other IP issues, and the searchable database available on the Internet from the European Patent Office for World and U.S. patents and patent applications.

INFORMATION SOURCES

Both primary and secondary research sources were used in this research. BCC interviewed primary sources from many different identified organizational stakeholder companies in the cardiovascular device market and supply industry, analyzed public documents, SEC filings, corporate white papers and other technical documentation for several dozen U.S. and international companies directly involved in manufacturing and distributing of cardiovascular devices and related equipment. We have deliberately not included the many resellers and retailers, focusing rather on the primary companies responsible for the development of the underlying technology. Additionally, BCC analyzed more than 1,000 design and utility patents filed in the U.S. and throughout the world focused on cardiovascular device-related inventions, reducing the number to 704 patents directly relevant to the subject matter of this market research report.

ANALYST CREDENTIALS

Sarah LoPrinzi is a business strategy consultant in several disparate vertical markets. She is a technology analyst and writer with more than 20 years of experience, who formerly served as a U.S. Army Intelligence Analyst. LoPrinzi specializes in market placement analysis and the development of technology and intellectual property strategies and has consulted with companies ranging from large international conglomerates to small, high-revenue-generating niche organizations, including IP documentation and analysis studies for Fortune 100 companies, with particular emphasis on IT technology and algorithmically based inventions.

Table of Contents

Cardiovascular Devices: Technologies and Global Markets

Chapter - 1: INTRODUCTION - - Complimentary

• STUDY GOALS AND OBJECTIVES
• REASONS FOR DOING THIS STUDY
• INTENDED AUDIENCE
• SCOPE OF REPORT
• METHODOLOGY
• INFORMATION SOURCES
• ANALYST CREDENTIALS
• RELATED BCC RESEARCH PUBLICATIONS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• SUMMARY
• SUMMARY (CONTINUED)
• SUMMARY TABLE GLOBAL MARKET FOR CARDIOVASCULAR DEVICES BY SEGMENT, THROUGH 2015 ($ MILLIONS)
• SUMMARY FIGURE GLOBAL MARKET FOR CARDIOVASCULAR DEVICES BY SEGMENT, 2007-2015 ($ MILLIONS)

Chapter-3: OVERVIEW

• CARDIOVASCULAR DEVICE CATEGORY DEFINITIONS
• CARDIOVASCULAR DIAGNOSTIC DEVICES
• CARDIOVASCULAR THERAPEUTIC DEVICES AND SYSTEMS
• PARTICIPANTS IN CARDIOVASCULAR DEVICE MARKET
• PARTICIPANTS IN CARDIOVASCULAR ... (CONTINUED)
  • FIGURE 1 FLOW CHART FOR A LARGE-TICKET CARDIOVASCULAR DEVICE PURCHASE
• PARTICIPANTS IN CARDIOVASCULAR ... (CONTINUED)
• PARTICIPANTS IN CARDIOVASCULAR ... (CONTINUED)
• MEDICAL DEVICE REGULATIONS
• AUSTRALIAN MEDICAL DEVICE AND THERAPEUTIC REGULATIONS
• CANADIAN MEDICAL DEVICE AND THERAPEUTIC REGULATIONS
• CHINESE MEDICAL DEVICE AND THERAPEUTIC REGULATIONS
• Chinese Medical Device and ...(Continued)
• Chinese Medical Device and ...(Continued)
• EUROPEAN UNION MEDICAL DEVICE AND THERAPEUTIC REGULATIONS
• European Union Medical Device...(Continued)
• European Union Medical Device...(Continued)
• European Union Medical Device...(Continued)
• INDIAN MEDICAL DEVICE AND THERAPEUTIC REGULATIONS
• Indian Medical Device and ...(Continued)
• JAPANESE MEDICAL DEVICE AND THERAPEUTIC REGULATIONS
• Japanese Medical Device and ...(Continued)
• DEVELOPMENT CYCLE AND APPROVAL PROCESS FOR HUMAN THERAPEUTICS
• DEVELOPMENT CYCLE AND APPROVAL...(CONTINUED)
• U.S. FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH)
• U.S. FDA Center for Devices and...(Continued)
• U.S. FDA Center for Devices and...(Continued)
• U.S. FDA Center for Devices and...(Continued)
• International FDA Reciprocal and Cooperative Agreements
• GHTF
• RISKS COMMON TO THE CARDIOVASCULAR DEVICE MARKET
• Financial and Business Risk
• Policy and Regulatory Risk
• Economic Risks
• Intellectual Property and Other Legal Issues
• Competition
• MAJOR STAKEHOLDER LAWSUITS
• Legal Actions within the Cardiovascular Device Industry
  • TABLE 1 LEGAL ACTIONS WITHIN THE CARDIOVASCULAR INDUSTRY
  • TABLE 1 (CONTINUED)
• Legal Actions within the ...(Continued)
• Legal Actions within the ...(Continued)
• Legal Actions within the ...(Continued)
• Legal Actions within the ...(Continued)

Chapter-4: CARDIOVASCULAR DEVICE MARKET ANALYSIS

• CARDIOVASCULAR DEVICE MARKET ANALYSIS
• ECONOMIC ANALYSIS FOR 2009 AND FORECASTED PERIOD
• FIGURE 2 EXAMPLE REVENUE TREND OVER TIME, 2004 - 2009
  • TABLE 2 FORECAST REVENUE AND CAGR FOR COMPANY A
• ECONOMIC ANALYSIS FOR 2009 AND ... (CONTINUED)
• NEW BUSINESS STRATEGIES IN A NEW ECONOMY
• MARKET BY PRODUCTS
  • TABLE 3 GLOBAL DIAGNOSTIC CARDIOVASCULAR DEVICE MARKET BY PRODUCT, THROUGH 2015 ($ MILLIONS)
  • TABLE 3 (CONTINUED)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 4 GLOBAL VALUE OF CARDIOVASCULAR INTERVENTION DEVICES BY PRODUCT, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 5 GLOBAL VALUE OF CARDIOVASCULAR SUPPORT COMPONENTS MARKET BY PRODUCT, THROUGH 2015 ($ MILLIONS)
  • TABLE 6 GLOBAL VALUE OF CARDIOVASCULAR FLUOROSCOPY BY PRODUCT, THROUGH 2015 ($ MILLIONS)
  • TABLE 7 GLOBAL VALUE OF HEARTBEAT AND ECHO IMAGING DEVICES BY TYPE, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 8 GLOBAL VALUE OF RADIOGRAPHY AND OTHER NONINVASIVE MEASUREMENT DEVICES BY PRODUCT CATEGORY, THROUGH 2015 ($ MILLIONS)
  • TABLE 9 GLOBAL VALUE OF COMPUTED TOMOGRAPHY BY PRODUCT CATEGORY, THROUGH 2015 ($ MILLIONS)
  • TABLE 10 GLOBAL VALUE OF ECG MONITOR MARKET BY TYPE OF SYSTEM, THROUGH 2015 ($ MILLIONS)
  • TABLE 11 GLOBAL VALUE OF CARDIOVASCULAR SURGICAL EQUIPMENT MARKET BY TYPE OF SYSTEM, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 12 GLOBAL VALUE OF INVESTIGATIONAL/PREDIAGNOSTIC MARKET BY TYPE OF DEVICE, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 13 GLOBAL VALUE OF CORONARY ARTERY DISEASE DEVICES MARKET BY TYPE OF EQUIPMENT, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 14 GLOBAL VALUE OF MISC. CONDITION SPECIFIC CARDIOVASCULAR INTERVENTION MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 15 GLOBAL VALUE OF CORONARY ARTERY BYPASS GRAFTING MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 16 GLOBAL VALUE OF TACHYARRHYTHMIA MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 17 GLOBAL VALUE OF PACEMAKERS AND ASSOCIATED EQUIPMENT MARKET, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 18 GLOBAL VALUE OF DEVICE-ORIENTED CARDIOVASCULAR DEVICE MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 19 GLOBAL VALUE OF PROCEDURALLY SPECIFIC THERAPY TREATMENT MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 20 GLOBAL VALUE OF DEVICES TO TREAT AND PREVENT HEART FAILURE MARKET, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 21 GLOBAL VALUE OF CARDIOVASCULAR SURGICAL MONITORING, THROUGH 2015 ($ MILLIONS)
  • TABLE 22 GLOBAL VALUE OF VASCULAR SURGERY EQUIPMENT MARKET, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
  • TABLE 23 GLOBAL VALUE OF CHEST-DRAINING EQUIPMENT FOR CARDIOVASCULAR SURGERY MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 24 GLOBAL VALUE OF INTERVENTION CARDIOLOGY SYSTEMS MARKET THROUGH 2015 ($ MILLIONS)
  • TABLE 24 (CONTINUED)
  • TABLE 25 GLOBAL VALUE OF CARDIAC RHYTHM DEVICES MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 26 GLOBAL VALUE OF CARDIAC DEFIBRILLATORS MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 27 GLOBAL VALUE OF CARDIAC STENTS AND SHUNTS MARKET, THROUGH 2015 ($ MILLIONS)
  • TABLE 28 GLOBAL VALUE OF CARDIAC CATHETERS MARKET, THROUGH 2015 ($ MILLIONS)
• MARKET BY PRODUCTS (CONTINUED)
• MARKET BY PRODUCTS (CONTINUED)
• MARKET BY PRODUCTS (CONTINUED)

Chapter-5: TECHNOLOGY

• TABLE 29 CARDIOVASCULAR PATENTS
• TABLE 29 (CONTINUED)
• TECHNOLOGY (CONTINUED)
• TECHNOLOGY (CONTINUED)
• PATENT ANALYSIS
• CARDIOVASCULAR INVENTIONS INVOLVING DIGITAL LOGIC
• CUMULATIVE PATENT ANALYSIS
• Cumulative Patents by Year
  • TABLE 30 CARDIOVASCULAR DEVICE-RELATED PATENTS BY YEAR OF PUBLICATION, 1974 - 2009
• Cumulative Patents by Year and Country
  • TABLE 31 CARDIOVASCULAR DEVICE-RELATED PATENTS BY YEAR AND COUNTRY, 1974 - 2009
• Patents by Invention Type
  • TABLE 32 CARDIOVASCULAR DEVICE-RELATED PATENTS BY INVENTION TYPE - TOP 20
• Patents by Life Cycle
  • TABLE 33 CARDIOVASCULAR DEVICE-RELATED PATENTS BY LIFE CYCLE
• Patents by Assignee
  • TABLE 34 CARDIOVASCULAR DEVICE-RELATED PATENTS BY ASSIGNEES - TOP 21
• Patents by Country
  • TABLE 35 PATENT COUNTRIES AND ASSOCIATED COUNTRY CODES
  • TABLE 35 (CONTINUED)
  • TABLE 35 (CONTINUED)
  • TABLE 36 CARDIOVASCULAR DEVICE-RELATED PATENTS BY COUNTRY

Chapter-6: COMPANY PROFILES

• ABBOTT LABORATORIES
• ACORN CARDIOVASCULAR
• ACORN CARDIOVASCULAR PATENTS
  • TABLE 37 ACORN CARDIOVASCULAR PATENTS BY COUNTRY (NUMBER)
  • TABLE 38 ACORN CARDIOVASCULAR PATENTS BY PUBLICATION YEAR, 2002-2009 (NUMBER)
  • TABLE 39 ACORN CARDIOVASCULAR PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 40 ACORN CARDIOVASCULAR PATENTS BY INVENTION TYPE (NUMBER)
• ANGIODYNAMICS, INC.
• ANGIODYNAMICS PATENTS
  • TABLE 41 ANGIODYNAMICS PATENTS BY COUNTRY (NUMBER)
  • TABLE 42 ANGIODYNAMICS PATENTS BY PUBLICATION YEAR, 2000-2009 (NUMBER)
  • TABLE 43 ANGIODYNAMICS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 44 ANGIODYNAMICS PATENTS BY INVENTION TYPE (NUMBER)
• ATRIUM MEDICAL CORP.
• ATRIUM MEDICAL PATENTS
  • TABLE 45 ATRIUM PATENTS BY COUNTRY (NUMBER)
  • TABLE 46 ATRIUM PATENTS BY PUBLICATION YEAR, 1982-2009 (NUMBER)
  • TABLE 47 ATRIUM PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 48 ATRIUM PATENTS BY INVENTION TYPE (NUMBER)
• BERLIN HEART GMBH
• BERLIN HEART PATENTS
  • TABLE 49 BERLIN HEART PATENTS BY COUNTRY (NUMBER)
  • TABLE 50 BERLIN HEART PATENTS BY PUBLICATION YEAR, 2001-2009 (NUMBER)
  • TABLE 51 BERLIN HEART PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 52 BERLIN HEART PATENTS BY INVENTION TYPE (NUMBER)
• BIOCARDIA
• BIOCARDIA PATENTS
  • TABLE 53 BIOCARDIA PATENTS BY COUNTRY (NUMBER)
  • TABLE 54 BIOCARDIA PATENTS BY PUBLICATION YEAR, 1999-2009 (NUMBER)
  • TABLE 55 BIOCARDIA PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 56 BIOCARDIA PATENTS BY INVENTION TYPE (NUMBER)
• BIOMEDIX, INC.
• BIOMEDIX PATENTS
  • TABLE 57 BIOMEDIX PATENTS BY COUNTRY (NUMBER)
  • TABLE 58 BIOMEDIX PATENTS BY PUBLICATION YEAR, 2005-2009 (NUMBER)
  • TABLE 59 BIOMEDIX PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 60 BIOMEDIX PATENTS BY INVENTION TYPE (NUMBER)
• BIOSENSE WEBSTER, INC.
• BIOSENSE WEBSTER PATENTS
  • TABLE 61 BIOSENSE WEBSTER PATENTS BY COUNTRY (NUMBER)
  • TABLE 62 BIOSENSE WEBSTER PATENTS BY PUBLICATION YEAR, 1998-2009 (NUMBER)
  • TABLE 63 BIOSENSE WEBSTER PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 64 BIOSENSE WEBSTER PATENTS BY INVENTION TYPE (NUMBER)
• BIOTRONIK GMBH & CO. KG
• BIOTRONIK PATENTS
  • TABLE 65 BIOTRONIK PATENTS BY COUNTRY (NUMBER)
  • TABLE 66 BIOTRONIK PATENTS BY PUBLICATION YEAR, 2003-2009 (NUMBER)
  • TABLE 67 BIOTRONIK PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 68 BIOTRONIK PATENTS BY INVENTION TYPE (NUMBER)
• BLUE MEDICAL DEVICES BV
• BLUE MEDICAL PATENTS
  • TABLE 69 BLUE MEDICAL PATENTS BY COUNTRY (NUMBER)
  • TABLE 70 BLUE MEDICAL PATENTS BY PUBLICATION YEAR, 2001-2009 (NUMBER)
  • TABLE 71 BLUE MEDICAL PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 72 BLUE MEDICAL PATENTS BY INVENTION TYPE (NUMBER)
• BOSTON SCIENTIFIC
• BOSTON SCIENTIFIC PATENTS
  • TABLE 73 BOSTON SCIENTIFIC PATENTS BY COUNTRY (NUMBER)
  • TABLE 74 BOSTON SCIENTIFIC PATENTS BY PUBLICATION YEAR, 1994-2009 (NUMBER)
  • TABLE 75 BOSTON SCIENTIFIC PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 76 BOSTON SCIENTIFIC PATENTS BY INVENTION TYPE (NUMBER)
• C.R. BARD, INC.
• C.R. BARD PATENTS
  • TABLE 77 C.R. BARD PATENTS BY COUNTRY (NUMBER)
  • TABLE 78 C.R. BARD PATENTS BY PUBLICATION YEAR, 1984-2009 (NUMBER)
  • TABLE 79 C.R. BARD PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 80 C.R. BARD PATENTS BY INVENTION TYPE (NUMBER)
• CARDIMA, INC.
• CARDIMA PATENTS
  • TABLE 81 CARDIMA PATENTS BY COUNTRY (NUMBER)
  • TABLE 82 CARDIMA PATENTS BY PUBLICATION YEAR, 1998-2000 (NUMBER)
  • TABLE 83 CARDIMA PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 84 CARDIMA PATENTS BY INVENTION TYPE (NUMBER)
• COOK MEDICAL, INC.
• COOK MEDICAL PATENTS
  • TABLE 85 COOK MEDICAL PATENTS BY COUNTRY (NUMBER)
  • TABLE 86 COOK MEDICAL PATENTS BY PUBLICATION YEAR, 1994-2009 (NUMBER)
  • TABLE 87 COOK MEDICAL PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 88 COOK MEDICAL PATENTS BY INVENTION TYPE (NUMBER)
• CORDIS CORP.
• CORDIS PATENTS
  • TABLE 89 CORDIS PATENTS BY COUNTRY (NUMBER)
  • TABLE 90 CORDIS PATENTS BY PUBLICATION YEAR, 1974-2008 (NUMBER)
  • TABLE 91 CORDIS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 92 CORDIS PATENTS BY INVENTION TYPE (NUMBER)
• CRYOCATH TECHNOLOGIES, INC.
• CRYOCATH PATENTS
  • TABLE 93 CRYOCATH PATENTS BY COUNTRY (NUMBER)
  • TABLE 94 CRYOCATH PATENTS BY PUBLICATION YEAR, 1988-2008 (NUMBER)
  • TABLE 95 CRYOCATH PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 96 CRYOCATH PATENTS BY INVENTION TYPE (NUMBER)
• DATASCOPE CORP.
• DATASCOPE PATENTS
  • TABLE 97 DATASCOPE PATENTS BY COUNTRY (NUMBER)
  • TABLE 98 DATASCOPE PATENTS BY PUBLICATION YEAR, 1976-2009 (NUMBER)
  • TABLE 99 DATASCOPE PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 100 DATASCOPE PATENTS BY INVENTION TYPE (NUMBER)
• EDWARDS LIFESCIENCES CORP.
• EDWARDS LIFESCIENCES PATENTS
  • TABLE 101 EDWARDS LIFESCIENCES PATENTS BY COUNTRY (NUMBER)
  • TABLE 102 EDWARDS LIFESCIENCES PATENTS BY PUBLICATION YEAR, 2000-2009 (NUMBER)
  • TABLE 103 EDWARDS LIFESCIENCES PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 104 EDWARDS LIFESCIENCES PATENTS BY INVENTION TYPE (NUMBER)
  • TABLE 104 (CONTINUED)
• JOHNSON & JOHNSON
• JOHNSON & JOHNSON PATENTS
  • TABLE 105 JOHNSON & JOHNSON PATENTS BY COUNTRY (NUMBER)
  • TABLE 106 JOHNSON & JOHNSON PATENTS BY PUBLICATION YEAR, 2007 AND 2008 (NUMBER)
  • TABLE 107 JOHNSON & JOHNSON PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 108 JOHNSON & JOHNSON PATENTS BY INVENTION TYPE (NUMBER)
• MAQUET, INC.
• MAQUET PATENTS
  • TABLE 109 MAQUET PATENTS BY COUNTRY (NUMBER)
  • TABLE 110 MAQUET PATENTS BY PUBLICATION YEAR, 2002-2009 (NUMBER)
  • TABLE 111 MAQUET PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 112 MAQUET PATENTS BY INVENTION TYPE (NUMBER)
• MEDTRONIC, INC.
• MEDTRONIC PATENTS
  • TABLE 113 MEDTRONIC PATENTS BY COUNTRY (NUMBER)
  • TABLE 114 MEDTRONIC PATENTS BY PUBLICATION YEAR, 1981-2009 (NUMBER)
  • TABLE 115 MEDTRONIC PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 116 MEDTRONIC PATENTS BY INVENTION TYPE (NUMBER)
• MERIT MEDICAL SYSTEMS, INC.
• MERIT MEDICAL SYSTEMS PATENTS
  • TABLE 117 MERIT MEDICAL SYSTEMS PATENTS BY COUNTRY (NUMBER)
  • TABLE 118 MERIT MEDICAL SYSTEMS PATENTS BY PUBLICATION YEAR, 1999-2008 (NUMBER)
  • TABLE 119 MERIT MEDICAL SYSTEMS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 120 MERIT MEDICAL SYSTEMS PATENTS BY INVENTION TYPE (NUMBER)
• NMT MEDICAL, INC.
• NMT MEDICAL PATENTS
  • TABLE 121 NMT MEDICAL PATENTS BY COUNTRY (NUMBER)
  • TABLE 122 NMT MEDICAL PATENTS BY PUBLICATION YEAR, 2005-2008 (NUMBER)
  • TABLE 123 NMT MEDICAL PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 124 NMT MEDICAL PATENTS BY INVENTION TYPE (NUMBER)
• NUMED CANADA, INC.
• NUMED PATENTS
  • TABLE 125 NUMED PATENTS BY COUNTRY (NUMBER)
  • TABLE 126 NUMED PATENTS BY PUBLICATION YEAR, 1990-2009 (NUMBER)
  • TABLE 127 NUMED PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 128 NUMED PATENTS BY INVENTION TYPE (NUMBER)
• SIEMENS MEDICAL SOLUTIONS USA, INC.
• SIEMENS PATENTS
  • TABLE 129 SIEMENS PATENTS BY COUNTRY (NUMBER)
  • TABLE 130 SIEMENS PATENTS BY PUBLICATION YEAR, 1995-2009 (NUMBER)
  • TABLE 131 SIEMENS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 132 SIEMENS PATENTS BY INVENTION TYPE (NUMBER)
• ST. JUDE MEDICAL, INC.
• ST. JUDE PATENTS
  • TABLE 133 ST. JUDE MEDICAL PATENTS BY COUNTRY (NUMBER)
  • TABLE 134 ST. JUDE MEDICAL PATENTS BY PUBLICATION YEAR, 2005-2009 (NUMBER)
  • TABLE 135 ST JUDE MEDICAL PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 136 ST JUDE MEDICAL PATENTS BY INVENTION TYPE (NUMBER)
• THE SPECTRANETICS CORP.
• SPECTRANETICS PATENTS
  • TABLE 137 SPECTRANETICS PATENTS BY COUNTRY (NUMBER)
  • TABLE 138 SPECTRANETICS PATENTS BY PUBLICATION YEAR, 1989-2009 (NUMBER)
  • TABLE 139 SPECTRANETICS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 140 SPECTRANETICS PATENTS BY INVENTION TYPE (NUMBER)
  • TABLE 141 VASCULAR SOLUTIONS PATENTS BY COUNTRY (NUMBER)
  • TABLE 142 VASCULAR SOLUTIONS PATENTS BY PUBLICATION YEAR, 1999-2008 (NUMBER)
  • TABLE 143 VASCULAR SOLUTIONS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 144 VASCULAR SOLUTIONS PATENTS BY INVENTION TYPE (NUMBER)
• VOLCANO THERAPEUTICS, INC.
• VOLCANO THERAPEUTICS PATENTS
  • TABLE 145 VOLCANO THERAPEUTICS PATENTS BY COUNTRY (NUMBER)
  • TABLE 146 VOLCANO THERAPEUTICS PATENTS BY PUBLICATION YEAR, 1997-2004 (NUMBER)
  • TABLE 147 VOLCANO THERAPEUTICS PATENTS BY LIFE CYCLE (NUMBER)
  • TABLE 148 VOLCANO THERAPEUTICS PATENTS BY INVENTION TYPE (NUMBER)

Chapter-7: APPENDIX

• APPENDIX
  • TABLE 149 BOSTON SCIENTIFIC RECENT AND PENDING LAWSUITS
  • TABLE 149 (CONTINUED)
  • TABLE 149 (CONTINUED)
  • TABLE 149 (CONTINUED)
  • TABLE 149 (CONTINUED)
  • TABLE 149 (CONTINUED)
  • TABLE 150 COMPANY CONTACT INFORMATION - FULL LISTING
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 150 (CONTINUED)
  • TABLE 151 PATENTS BY ASSIGNEE - FULL LISTING
  • TABLE 151 (CONTINUED)
  • TABLE 152 PATENTS BY INVENTION TYPE/WEB - FULL LISTING
  • TABLE 153 MARKET SHAREHOLDERS BY YEAR AND ESTIMATED MARKET SHARE, 2006 - 2015 (%)
  • TABLE 153 (CONTINUED)
  • TABLE 153 (CONTINUED)

Press Release

CARDIOVASCULAR DEVICES TO BE WORTH $97.4 BILLION GLOBALLY IN 2015

Related Reports